1-6 of 6
Robert P. Byington
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial

Peter E. Linz, Laura C. Lovato, Robert P. Byington, Patrick J. O’Connor, Lawrence A. Leiter, Daniel Weiss, Rex W. Force, John R. Crouse, Faramarz Ismail-Beigi, Debra L. Simmons, Vasilios Papademetriou, Henry N. Ginsberg, Marshall B. Elam
Journal: Diabetes Care
Diabetes Care 2014;37(3):686–693
https://doi.org/10.2337/dc13-0790
Published: 11 February 2014
View article titled, Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial
Open the PDF for Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial in another window
Includes: Supplementary data
Journal Articles

Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial

Michael E. Miller, Jeff D. Williamson, Hertzel C. Gerstein, Robert P. Byington, William C. Cushman, Henry N. Ginsberg, Walter T. Ambrosius, Laura Lovato, William B. Applegate, for the ACCORD Investigators
Journal: Diabetes Care
Diabetes Care 2014;37(3):634–643
https://doi.org/10.2337/dc13-1545
Published: 11 February 2014
View article titled, Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial
Open the PDF for Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial in another window
Includes: Supplementary data
Journal Articles

Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial

Matthew C. Riddle, MD, Walter T. Ambrosius, PHD, David J. Brillon, MD, John B. Buse, MD, PHD, Robert P. Byington, MPH, PHD, Robert M. Cohen, MD, David C. Goff, Jr., MD, PHD, Saul Malozowski, MD, PHD, Karen L. Margolis, MD, MPH, Jeffrey L. Probstfield, MD, Adrian Schnall, MD, Elizabeth R. Seaquist, MD, for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Investigators
Journal: Diabetes Care
Diabetes Care 2010;33(5):983–990
https://doi.org/10.2337/dc09-1278
Published: 01 May 2010
View article titled, Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial
Open the PDF for Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial in another window
Includes: Supplementary data
Journal Articles

The Burden of Treatment Failure in Type 2 Diabetes: Response to Brown et al.

Denise G. Simons-Morton, MD, PHD, Saul Genuth, MD, Robert P. Byington, PHD, Hertzel C. Gerstein, MD, MSC, William T. Friedewald, MD
Journal: Diabetes Care
Diabetes Care 2005;28(3):761–762
https://doi.org/10.2337/diacare.28.3.761
Published: 01 March 2005
View article titled, The Burden of Treatment Failure in Type 2 Diabetes: <subtitle>Response to Brown et al.</subtitle>
Open the PDF for The Burden of Treatment Failure in Type 2 Diabetes: <subtitle>Response to Brown et al.</subtitle> in another window
Journal Articles

Isradipine in Prediabetic Hypertensive Subjects

Robert P Byington, PHD, Curt D Furberg, MD, Timothy E Craven, MS, Marco Pahor, MD, James R Sowers, MD
Journal: Diabetes Care
Diabetes Care 1998;21(12):2103–2110
https://doi.org/10.2337/diacare.21.12.2103
Published: 01 December 1998
View article titled, Isradipine in Prediabetic Hypertensive Subjects
Open the PDF for Isradipine in Prediabetic Hypertensive Subjects in another window
Journal Articles

Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM

Patrizio Tatti, MD, Marco Pahor, MD, Robert P Byington, PHD, Patrizia Di Mauro, MD, Riccardo Guarisco, MD, Giovanna Strollo, MD, Felice Strollo, MD
Journal: Diabetes Care
Diabetes Care 1998;21(4):597–603
https://doi.org/10.2337/diacare.21.4.597
Published: 01 April 1998
View article titled, Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM
Open the PDF for Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM in another window